Ensuring Access through Collaborative Health (EACH) & the Patient Inclusion Council (PIC)

A two-part, national coalition aiming to ensure patients have a voice as policymakers at the US state and national levels are reviewing drug costs. We will be helping both organizations and patients navigate these complex processes, while identifying and connecting them to opportunities  to engage every step of the way.

Our efforts will address both the Centers for Medicare and Medicaid Services (CMS) Drug Price Negotiations and state level Prescription Drug Affordability Boards (PDABs).

While AiArthritis leads this national coalition, it is open to all disease groups affected by drug reviews; it is not Autoimmune Arthritis and Autoinflammatory Arthritis disease specific.